InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: Fred Kadiddlehopper post# 4234

Monday, 11/23/2015 4:56:07 PM

Monday, November 23, 2015 4:56:07 PM

Post# of 8570
"Given the company's focus in oncology and growth trajectory, a satellite office in San Francisco is an important step to help us attract additional talented team members whose focus will be to expand our clinical programs and advance towards our goal of commercializing our investigational new drug, PEGPH20," said Helen Torley, president and CEO. "The Bay Area satellite location will give us the ability to augment our already strong San Diego work force."

No where is research or labs implied. Support for growing clinical trials and commercialization.

Why would Dr. Torley mislead the reason for expansion?

In 4-5 months there will 4 Peg trials recruiting and at least two of those global. What else is in the works? I can see the need for expansion and justification for the area chosen.

Will this lead to more expansion? Sure hope so!!!

Good Luck to you Fritz!!!

Rod

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News